On June 30, 2022, Bridge Biotherapeutics, Inc. closed the transaction. The company issued 292,680 shares for gross proceeds of KRW 2,999,970,000 in the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,725 KRW | +4.81% | +19.00% | -17.05% |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
6,630 KRW | -2.07% | +3.27% | 76.89M | ||
3,335 KRW | -2.77% | +0.60% | 556M | ||
2,725 KRW | +4.81% | +19.00% | 46.3M | ||
2,145 KRW | -1.83% | 0.00% | 84.63M | ||
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-17.05% | 46.3M | |
+18.34% | 125B | |
+15.06% | 108B | |
-6.39% | 23.64B | |
+2.39% | 22.39B | |
-12.11% | 17.78B | |
-41.64% | 16.43B | |
-12.07% | 16.34B | |
+1.05% | 13.56B | |
+25.87% | 11.59B |
- Stock Market
- Equities
- A288330 Stock
- News Bridge Biotherapeutics, Inc.
- Bridge Biotherapeutics, Inc. announced that it has received KRW 2.99997 billion in funding from a group of investors